157 related articles for article (PubMed ID: 6207093)
1. On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
Balldin G; Borgström A; Marks WH; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):751-6. PubMed ID: 6207093
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases.
Kitahara T; Takatsuka Y; Fujimoto KI; Tanaka S; Ogawa M; Kosaki G
Clin Chim Acta; 1980 Apr; 103(2):135-43. PubMed ID: 6154549
[TBL] [Abstract][Full Text] [Related]
3. Partition of trypsin and Kazal inhibitor in reaction mixtures with human serum.
Eddeland A
Hoppe Seylers Z Physiol Chem; 1979 Feb; 360(2):145-9. PubMed ID: 422124
[TBL] [Abstract][Full Text] [Related]
4. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
Marks WH; Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
[TBL] [Abstract][Full Text] [Related]
5. [Changes in serum pancreatic enzymes and pancreatic secretory trypsin inhibitor in patients with severe acute pancreatitis].
Ogawa M; Matsuda K; Matsuda Y; Nakaguchi K; Miyauchi K; Nishijima J; Mori T; Horikawa Y; Kurihara M
Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1241-4. PubMed ID: 2418344
[TBL] [Abstract][Full Text] [Related]
6. Appearance mechanism and molecular heterogeneity of serum pancreatic secretory trypsin inhibitor (PSTI).
Nakano I; Funakoshi A; Sumii T; Miyazaki K; Oogami Y; Kimura T; Ibayashi H
Gastroenterol Jpn; 1985 Aug; 20(4):354-60. PubMed ID: 4054512
[TBL] [Abstract][Full Text] [Related]
7. Studies on the pancreatic secretory trypsin inhibitor in plasma and its complex with trypsin in vivo and in vitro.
Eddeland A; Ohlsson K
Scand J Clin Lab Invest; 1978 Oct; 38(6):507-15. PubMed ID: 81511
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of immunoreactive PSTI in acute abdominal disorders, with special reference to a possible extrapancreatic PSTI production.
Lasson A; Borgström A; Ohlsson K
Clin Chim Acta; 1986 Nov; 161(1):37-46. PubMed ID: 2434267
[TBL] [Abstract][Full Text] [Related]
9. Human cationic, pancreatic elastase in acute pancreatitis.
Håkansson HO; Borgström A; Ohlsson K
Scand J Clin Lab Invest; 1993 Feb; 53(1):17-24. PubMed ID: 7680823
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.
Mero M; Tenhunen R; Pessi T; Sandholm M
Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
Berling R; Borgström A; Ohlsson K
Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
[TBL] [Abstract][Full Text] [Related]
12. Serum pancreatic secretory trypsin inhibitor in pancreatic disease.
Otsuki M; Oka T; Suehiro I; Okabayashi Y; Ohki A; Yuu H; Baba S
Clin Chim Acta; 1984 Sep; 142(2):231-40. PubMed ID: 6209036
[TBL] [Abstract][Full Text] [Related]
13. The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.
Satake K; Inui A; Sogabe T; Yoshii Y; Nakata B; Tanaka H; Chung YS; Hiura A; Umeyama K
Int J Pancreatol; 1988 Jul; 3(5):323-31. PubMed ID: 2459273
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of serum pancreatic secretory trypsin inhibitor (PSTI) in acute pancreatitis].
Chen BG
Zhonghua Wai Ke Za Zhi; 1988 Jun; 26(6):365-6, 384. PubMed ID: 3229243
[No Abstract] [Full Text] [Related]
15. A radioimmunoassay for rat pancreatic secretory trypsin inhibitor.
Marks WH; Ohlsson K
Scand J Gastroenterol; 1983 May; 18(3):401-5. PubMed ID: 6673065
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic secretory trypsin inhibitor as an acute phase reactant.
Ogawa M
Clin Biochem; 1988 Jan; 21(1):19-25. PubMed ID: 2449986
[TBL] [Abstract][Full Text] [Related]
17. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
[TBL] [Abstract][Full Text] [Related]
18. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic secretory trypsin inhibitor-like immunoreactivity in pancreatectomized patients.
Halila H; Huhtala ML; Schröder T; Kiviluoto T; Stenman UH
Clin Chim Acta; 1985 Dec; 153(3):209-16. PubMed ID: 3935345
[TBL] [Abstract][Full Text] [Related]
20. [Experimental studies on the significance of the measurement of serum pancreatic secretory trypsin inhibitor in acute pancreatitis].
Tanaka T; Yamamoto M; Okumura S; Oyanagi H; Saitoh Y
Nihon Shokakibyo Gakkai Zasshi; 1985 Aug; 82(8):1914-23. PubMed ID: 4068313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
